Skip to main content
. 2020 Sep 2;40(2):177–182. doi: 10.14366/usg.20085

Table 1.

Summary of studies applying deep learning to diffuse liver disease

Study Task Data used for deep learning US system Total no. of images (total no. of patients) No. of validation set images (no. of patients) Ground truth Method
Xue et al. (2020) [2] Fibrosis B-mode+elastography One 2,330 (466) 510 (102) Pathology CNN
Lee et al. (2020) [3] Fibrosis B-mode ≥4 14,583 (3,975) 300 (266) for internal validation 1,232 (572) for external validation Pathology, elastography, clinical diagnosis CNN
Wang et al. (2019) [6] Fibrosis Elastography One 1,990 (398) 660 (132) Pathology CNN
Treacher et al. (2019) [7] Fibrosis B-mode elastography image One 3,500 (326) 524 (N/A) Shear wave velocity CNN
Byra et al. (2018) [8] Fibrosis B-mode One 550 (55) Leave-one-out cross-validation Pathology CNN+SVM
Meng et al. (2017) [11] Fibrosis B-mode N/A 279 (279) 77 (77) Clinical diagnosis CNN
Liu et al. (2017) [10] Fibrosis B-mode One 91 (91) 3-fold cross-validation Clinical diagnosis (Child-Pugh classification, CT, US) CNN+SVM
Han et al. (2020) [4] Steatosis RF US data One 2,560 RF signals per participant (204) 2,560 RF signals per participant (102) MRI-derived proton density fraction CNN
Cao et al. (2020) [5] Steatosis B-mode One 1,092 (N/A) 240 (240) US scoring system CNN
Biswas et al. (2018) [9] Steatosis B-mode One 63 (63) 10-fold cross-validation Pathology CNN

US, ultrasonography; CNN, convolutional neural network; N/A, not available; SVM, support vector machine; CT, computed tomography; RF, radiofrequency; MRI, magnetic resonance imaging.